You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Intrinsic Value | Fundamental Analysis

Returns | 1W : -2.4% , 1M : 9.2%,1Y : 50.7%
BOM : 524715     NSE : SUNPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
May 18,2021
Price(EOD): Rs. 690.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 165,755.64 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES -2.4% 9.2% 50.7%
DR REDDYS LABORATORIES -1.5% 7.7% 40.7%
DIVIS LABORATORIES -1.9% 5.7% 70.9%
CIPLA -0.7% -3.3% 54.7%
BIOCON -0.7% -4.8% 15%
AUROBINDO PHARMA -2.5% 9.9% 50.5%
LUPIN -0.9% 13.1% 37.8%
TORRENT PHARMACEUTICALS 0.3% 6.1% 14.8%
CADILA HEALTHCARE -4% 19.9% 81.5%


FUNDAMENTAL ANALYSIS OF SUN PHARMACEUTICAL INDUSTRIES

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than SUN PHARMACEUTICAL INDUSTRIES Premium


VALUATION OF SUN PHARMACEUTICAL INDUSTRIES

 
Valuation Score
Ratio Consolidated
P/E
P/B
P/S
44.03
P/E Calculated based on EPS of 15.69
[ Mar2020 - Consolidated Results ]

3.66
P/B Calculated based on Book Value of 188.66
[ Mar2020 - Consolidated Results ]

5
P/S Calculated based on Revenues of 33160.1 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than SUN PHARMACEUTICAL INDUSTRIES Premium


FAIR VALUE OF SUN PHARMACEUTICAL INDUSTRIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
133%
-29%
-32%

SHARE PRICE MOMENTUM OF SUN PHARMACEUTICAL INDUSTRIES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.26
0.28
0.31
0.28
0.18
0.25
0.27
0.23
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
8.62 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
3.32%
6.44%
12.82%
-1.55%
8.36%
32.67%
60.07%
87.37%
QtrlyTrend
6
Latest Qtr: Dec2020

SUN PHARMACEUTICAL INDUSTRIES related INDICES

BSE Indices1W1M1Y
S&P BSE SENSEX 2.1% 2.9% 59.3%
S&P BSE SENSEX50 1.8% 3.6% 63.5%
S&P BSE 100 1.7% 4.1% 63.4%
S&P BSE 100 LARGECAP TMC 1.7% 4.2% 63.2%
S&P BSE 100 ESG INDEX 1.7% 4.1% 69%
S&P BSE CARBONEX 1.7% 4.1% 65.1%
S&P BSE LARGECAP 1.6% 4.1% 63.1%
S&P BSE LARGE MIDCAP 1.6% 4.5% 65.3%
S&P BSE 200 1.6% 4.6% 66.5%
S&P BSE 250 LARGEMIDCAP 1.6% 4.6% 66.7%
S&P BSE 500 1.6% 4.9% 69.2%
S&P BSE ALLCAP 1.5% 5.2% 70.6%
MFG 1.3% 5.4% 56.8%
S&P BSE 500 SHARIAH 1.1% 3.4% 66.6%
S&P BSE GREENEX 0.3% 4.1% 70.5%
S&P BSE DIVIDEND STABILITY -0.9% 9.2% 68.1%
S&P BSE HEALTHCARE -1.6% 6.9% 59.5%
NSE Indices1W1M1Y
NIFTY 50 1.7% 3.6% 63.2%
NIFTY 100 1.7% 4.1% 62.2%
NIFTY100 LIQ 15 1.6% 8.1% 63.9%
NIFTY 200 1.6% 4.5% 65.3%
NIFTY 500 1.6% 4.9% 68.6%
NIFTY 100 EQUAL WEIGHT 1% 6.8% 71%
NIFTY LARGE MIDCAP 250 0.1% 4.2% 69.7%
NIFTY PHARMA -1.7% 6.5% 51.1%

FAQ [Frequently Asked Questions]


Is SUNPHARMA good for long term investment?

As on 18-May-2021, the Fundamentals of SUNPHARMA are Strong and hence it's good for long term investment! See Financial Performance of SUN PHARMACEUTICAL INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SUNPHARMA UnderValued or OverValued?

As on 18-May-2021, SUNPHARMA is Under Valued and hence a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SUNPHARMA ?

As on 18-May-2021, the Intrinsic Value of SUNPHARMA is Rs. 977.71 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 296.08
Fair Value [Median EV / Sales Model] : Rs. 977.71
Fair Value [Median Price / Sales Model] : Rs. 1,017.21
Median Fair Value of SUNPHARMA : Rs. 977.71

Is SUNPHARMA trading at a Premium or Discount?

As on 18-May-2021, SUNPHARMA is trading at a Discount of -29% based on the Median Intrinsic Value!

Is it right time to buy SUNPHARMA shares?

As on 18-May-2021, SUNPHARMA is Under Valued and hence a good buying opportunity according to Share Valuation at this time!
The Share Price Momentum is also bullish which indicates strong buying across the board!

What is the Financial Performance of Industry Peers of SUNPHARMA?

Check out Financials of Industry Peers using below links:
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD
Financials of ALKEM LABORATORIES LTD

What are the Frequent Comparisons with SUNPHARMA?

SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs DIVIS LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs CIPLA LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs BIOCON LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs AUROBINDO PHARMA LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs LUPIN LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs CADILA HEALTHCARE LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs ABBOTT INDIA LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs ALKEM LABORATORIES LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z